Barclays »

Tandem Diabetes Care shares owned by Barclays

Quarter-by-quarter ownership of Tandem Diabetes Care shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Tandem Diabetes Care

Tip: Access up to 7 years of quarterly data

All positions including Tandem Diabetes Care held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tandem Diabetes Care by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $403k 462k 0.87
2025-06-30 $2.0M 2.0M 0.97
2025-03-31 $1.7M 1.8M 0.94

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Tandem Diabetes Care

Deerfield Management Company
Linden Advisors
Bank Of Montreal
Advent Capital Management
Camden Asset Management
OZ Management
Calamos Advisors
Shenkman Capital Management
Walleye Trading Advisors
Morgan Stanley
FMR
Capstone Investment Advisors
Leucadia National Corporation
BlackRock
New York State Common Retirement Fund

View all funds holding Tandem Diabetes Care